Protalix Biotherapeutics Inc. Stock
Heavy losses for Protalix Biotherapeutics Inc. today as the stock fell by -€0.045 (-4.260%).
With 1 Buy predictions and 2 Sell predictions the community is currently undecided on Protalix Biotherapeutics Inc..
On the other hand, the target price of 2 € is above the current price of 1.03 € for Protalix Biotherapeutics Inc., so the potential is actually 94.55%.
Our community identified positive and negative aspects for Protalix Biotherapeutics Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Protalix Biotherapeutics Inc. stock. On the other hand our users think that "Growth compared to competition" could be a problem in the future.
Pros and Cons of Protalix Biotherapeutics Inc. in the next few years
Pros
?
S********** s********
?
B****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Protalix Biotherapeutics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Protalix Biotherapeutics Inc. | -4.260% | -9.387% | -4.149% | -45.795% | -37.527% | -58.880% | -73.842% |
Compugen Ltd. | -1.590% | -10.468% | 12.291% | 123.333% | 23.313% | - | - |
Organovo Holdings Inc. | 2.430% | -2.061% | -9.519% | -43.421% | -11.988% | -87.630% | -91.147% |
Chromadex Corp | 3.150% | -8.333% | -18.012% | 100.000% | 97.015% | -61.176% | - |